In this study, we tested the hypothesis that prostaglandin I 2 (PGI 2 ), a lipid product formed in the cyclooxygenase (COX) pathway of arachidonic acid metabolism, suppresses IL-33-induced cytokine responses by hILC2.
Methods hILC2 (Lin-CD25+CD127+ cells) were purified by flow cytometric cell sorting from peripheral blood mononuclear cells and stimulated with IL-33 and IL-2 in the presence of the PGI 2 analog cicaprost or vehicle.
Results
We found that hILC2 expressed the IL-33 receptor and the PGI 2 receptor IP. Treatment of the cells with cicaprost significantly decreased IL-5 and IL-13 production, and the inhibition was associated with lower levels of mRNA expression of the transcription factors involved in the production of these cytokines and ILC2 development including gata3, gfi-1, Ror-α and Id2. cAMP-elevating reagents such as db-cAMP and PGE 2 had a similar inhibitory effect on IL-5 and IL-13 production by hILC2.
Conclusions
These data indicate that PGI 2 inhibits hILC2 cytokine secretion and suggest that use of COX inhibiting drugs may increase the risk of developing allergic diseases by augmenting ILC2 cytokine responses. 
